Your browser doesn't support javascript.
Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP).
Novembre, Elio; Tosca, Mariangela; Caffarelli, Carlo; Calvani, Mauro; Cardinale, Fabio; Castagnoli, Riccardo; Chiappini, Elena; Cravidi, Claudio; Del Giudice, Michele Miraglia; Duse, Marzia; Licari, Amelia; Manti, Sara; Martelli, Alberto; Ricci, Giampaolo; Pingitore, Giuseppe; Marseglia, Gian Luigi.
  • Novembre E; Allergy Unit, Department of Pediatrics, Meyer Children's University Hospital, Florence, Italy.
  • Tosca M; Allergy Center, Istituto Giannina Gaslini, Genoa, Italy.
  • Caffarelli C; Pediatric Clinic, Department of Medicine and Surgery, University of Parma, Via Gramsci, 14, Parma, Italy. carlo.caffarelli@gmail.com.
  • Calvani M; Operative Unit of Pediatrics, S. Camillo-Forlanini Hospital, Rome, Italy.
  • Cardinale F; Pediatric Unit, Azienda Ospedaliero-Universitaria "Policlinico- Giovanni XXIII, Bari, Italy.
  • Castagnoli R; Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
  • Chiappini E; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
  • Cravidi C; Paediatric Infectious Diseases Unit, Department of Health Sciences, Anna Meyer Children's University Hospital, University of Florence, Florence, Italy.
  • Del Giudice MM; ATS Pavia, Pavia, Italy.
  • Duse M; Department of Woman and Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Licari A; Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.
  • Manti S; Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
  • Martelli A; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
  • Ricci G; Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Catania, Italy.
  • Pingitore G; Pediatrician at the University of Pavia, Pavia, Italy.
  • Marseglia GL; Alma Mater Studiorum, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Ital J Pediatr ; 48(1): 76, 2022 May 16.
Article in English | MEDLINE | ID: covidwho-1846857
ABSTRACT
BNT162b2 vaccine, developed by BioNTech and Pfizer ha recently approved for use in children aged 5 to 11 years. Recent data show evidence of safety on the administration and serious adverse events have been rarely reported. However, allergic systemic reactions could occur. In some cases, a correct allergic evaluation allows identifying patients at risk of developing an anaphylactic reaction. Risk assessment of allergic reactions to COVID-19 vaccines is useful to limit contraindications to vaccination and help to safely vaccinate people supposed to be at risk of allergic reactions.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / COVID-19 / Anaphylaxis Type of study: Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Child / Humans Language: English Journal: Ital J Pediatr Journal subject: Pediatrics Year: 2022 Document Type: Article Affiliation country: S13052-022-01272-z

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / COVID-19 / Anaphylaxis Type of study: Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Child / Humans Language: English Journal: Ital J Pediatr Journal subject: Pediatrics Year: 2022 Document Type: Article Affiliation country: S13052-022-01272-z